Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Recursion, about how the company uses AI and machine learning to accelerate drug discovery and development at scale. Tune in to hear Gibson discuss how AI is transforming the biopharmaceutical industry by increasing efficiency and lowering discovery costs.

Om Podcasten

Explore how the latest technologies are shaping our world, from groundbreaking discoveries to transformative sustainability efforts. The NVIDIA AI Podcast shines a light on the stories and solutions behind the most innovative changes, helping to inspire and educate listeners. Every week, we’ll bring you another tale, another 30-minute interview, as we build a real-time oral history of AI that’s already garnered nearly 6.5 million listens and been acclaimed as one of the best AI and machine learning podcasts. Listen in and get inspired. More information: https://ai-podcast.nvidia.com/